The diabetic foot: The importance of biofilms and wound bed preparation

Current Diabetes Reports

Volumn 6, Issue 6, 2006, Pages 439-445

  Davis, Stephen C ^b   Martinez, Lisa ^b   Kirsner, Robert ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; APOLACTOFERRIN; COCKTAIL ENZYME; ENZYME; GENTAMICIN; LACTOFERRIN; LYSOZYME; PHOTOSENSITIZING AGENT; PSEUDOMONIC ACID; RECOMBINANT LACTOFERRIN; RECOMBINANT PROTEIN; SILVER; SILVER NITRATE; TOPICAL ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BIOFILM; CHRONIC WOUND; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEBRIDEMENT; DIABETIC FOOT; DRUG PENETRATION; ELECTROPHORESIS; ELECTROPORATION; ELECTROSTIMULATION THERAPY; HUMAN; HYPERBARIC OXYGEN; INFECTION SENSITIVITY; MONOTHERAPY; NONHUMAN; QUORUM SENSING; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRASOUND THERAPY; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND DRESSING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; DEBRIDEMENT; DIABETIC FOOT; HUMANS; MODELS, ANIMAL; WOUNDS AND INJURIES;

EID: 33845411123     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-006-0076-x     Document Type: Review

References (54)

1. Reiber G, Lipsky B, Gibbons G: The burden of diabetic foot ulcers. Am J Surg 1998, 176(2A):5S-10S.
2. Ramsey S, Newton K, Blough D, et al.: Incidences, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999, 22:382-387.
3. Loots M, Lamme E, Zeegelaar J, et al.: Differences in cellular infiltrates and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998, 111:850-857.
4. Jeffcoate W, Price P, Harding K: Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev 2004, 20(suppl 1):S78-S89.
5. Lipsky BA, Bernendt AR, Deery HG, et al.: Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg 2006, 117(7 suppl):212S-238S.
6. Robson MC: Wound infection: a failure of healing caused by an imbalance of bacteria. Surg Clin North Am 1997, 77:637-650.
7. Hunt JA: Foot infections in diabetes are rarely due to a single micro-organism. Diabet Med 1992, 9:749-752.
8. Costerton JW, Lewandowski Z, Caldwell DE, et al.: Microbial biofilm. In Annual Review of Microbiology, vol 49. Edited by Ornston LN, et al. Palo Alto, CA: Annual Reviews; 1995:711-745.
9. Geesey GG, Richardson WT, Yeomans HG, et al.: Microscopic examination of natural sessile bacterial populations from an alpine stream. Can J Microbiol 1977, 23:1733-1736.
10. Potera C: Forging a link between biofilms and disease. Science 1999, 283:1837-1839.
11. Parsek M, Pradeep S: Bacterial biofilms: an emerging link to disease pathogenesis. In Annual Review of Microbiology, vol 57. Edited by Ornston LN, et al. Palo Alto, CA: Annual Reviews; 2003:677-701.
12. Percival L, Bowler P: Biofilms and their potential role in wound healing. Wounds 2004, 16:234-240.
13. Mertz P: Cutaneous biofilms: friend or foe? Wounds 2003, 15:129-132.
14. Camilli A, Bassler B: Bacterial small-molecule signaling pathways. Science 2006, 311:1113-1116.
15. Serralta V, Harrison-Balestra C, Cazzaniga A, et al.: Lifestyles of bacteria in wounds: presence of biofilms? Wounds 2001, 13:29-34.
16. Davis SC, Bouzari N: Development of antimicrobials for wound care: in vitro and in vivo assessments. Wounds 2004, 16:344-347.
17. Davis SC, Cazzaniga AL, Eaglstein WH, Mertz PM: Over-the-counterantimicrobial bandages and proliferation of a common wound pathogen. Arch Dermatol Res 2005, 297:190-195.
18. Mah T, O'Toole G: Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001, 9:34-39.
19. Leid J: Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002, 70:6339-6345.
20. Falanga V: Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen 2000, 8:347-352.
21. Brem H, Balledux J, Sukkarieh T, et al.: Healing of venous ulcers of long duration with a bilayered living skin substitute. Results from a general surgery and dermatology department. Dermatol Surg 2001, 27:915-919.
22. Schultz Gs, Barillo DJ, Mozingo DW, Chin GA: Wound bed preparation and a brief history of TIME. Int Wound J 2004, 1:19-32.
23. Sibbald RG, Williamson D, Orsted HL, et al.: Preparing the wound bed - debridement, bacterial balance and moisture balance. Ostomy Wound Manage 2000, 46:14-35.
24. Warriner R, Burrell R: Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 2005, 18(suppl 1):2-12.
25. Brem H, Sheehan P, Boulton A: Protocol for treatment of diabetic foot ulcers. Am J Surg 2004, 187:1S-10S.
26. Ennis W, Formann P, Mozen N, et al.: Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study. Ostomy Wound Manage 2005, 51:24-39.
27. Breuing K, Bayer L, Neruwalder J, Orgill D: Early experience using low-frequency ultrasound in chronic wounds. Ann Plast Surg 2005, 55:183-187.
28. Carmen JC, Roeder BL, Nelson, JL, et al.: Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl 2004, 18:237-245.
29. Bergin S, Wraight P: Silver Based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006, (1):CD005082.
30. Nelson E, O'Mearat S, Goldert S, et al.: Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 2006, 23:348-359.
31. Roeckly-Wiedmann I, Bennett M, Kranke P: Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 2005, 92:24-32.
32. Ansari M, Shukla V: Foot infections. Int J Low Extrem Wounds 2005, 4:74-87.
33. Hon DC, Mackay RD, Haliday B, et al.: The effect of O2 tension on the microbicidal function of leukocytes in wounds and in vitro. Surg Forum 1976, 27:18-20.
34. Travis J, Salvesen GS: Human plasma proteinase inhibitors. Ann Rev Biochem 1985, 52:655-709.
35. Niinikoski H: Effect of oxygen supply on wound healing and formation of granulation tissue. Acta Physiol Scand 1969, 334(suppl):1-72.
36. Silver IA: Local and systemic factors which affect the proliferation of fibroblasts. In Biology of Fibroblasts. Edited by Kulonen E, Pikkarainen J. New York, NY: Academic Press; 1973:507-520.
37. Meltzen T, Myers B: The effect of hyperbaric oxygen on the bursting strength and the rate of vascularization of skin wounds in the rat. Am Surg 1986, 52:659-662.
38. Cianci P, Hunt TK: Adjunctive hyperbaric oxygen therapy in treatment of diabetic foot wounds. In The Diabetic Foot, edn 5. Edited by Levin ME, et al. St. Louis: Mosby; 1993:305-319.
39. Hammarlund C, Sundberg T: Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast Reconstr Surg 1994, 93:829-833.
40. Mader JT, Borwn GL, Guckian JC, et al.: A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 1980, 142:915-922.
41. Hehenberger K, Brismar K, Lind F, Kratz G: Dose-dependent hyperbaric oxygen stimulation of human fibroblasts proliferation. Wound Repair Regen 1997, 5:147-150.
42. Kurz A, Sessler D, Lenhardt, et al.: Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996, 334:1209-1215.
43. Hopf HW, Hunt TK, West JM, et al.: Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997, 132:997-1004.
44. Eginton M, Brown K, Seabrook G, et al.: A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann Vasc Surg 2003, 17:645-649.
45. Venturi M, Attinger C, Mesbahi A, et al.: Mechanisms and clinical applications of the vaccum assisted closure (VAC) device. Am J Clin Dermatol 2005, 6:185-194.
46. Labrecque J, Bodet C, Chandad F, Grenier D: Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gigivalis. J Antimicrob Chemother 2006, 58:439-443.
47. Kustos I, Kustos T, Kilar F, et al.: Effect of antibiotic treatment on bacterial attachment to a DePuy Enduron orthopedic implant. Chemotherapy 2005, 51:286-290.
48. Valenti P, Berlutti F, Conte M, et al.: Lactoferrin functions: current status and perspectives. J Clin Gastroenterol 2004, 38(suppl 2):s127-s129.
49. Weinberg E: Suppression of biofilm formation by iron limitation. Med Hypotheses 2004, 63:863-865.
50. Singh P, Parsek M, Greenberg P, Welsh M: A component of innate immunity prevents bacterial biofilm formation. Nature 2002, 417:552-555.
51. Nandi S, Yalda D, Lu S, et al.: Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain. Transgenic Res 2005, 14:237-249.
52. Johnson PG, Oseroff AR: Electrically enhanced percutaneous delivery of delta-aminolevulinic acid using electric pulses and DC potential. Photochem Photobiol 2002, 75:534-540.
53. Wade DS, Calfee MW, Rocha ER, et al.: Regulation of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa. J Bacteriol 2005, 187:4372-4380.
54. Sauer K, Cullen MC, Rickard AH, et al.: Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J Bacteriol 2004, 186:7312-7326.